Floatz logo

Ropinirole

Parkinson's Disease

Teva Neuroscience, Inc.Small moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
73/ 100

Competitive context

256 Active assets in the Parkinson's Disease cohort.

Asset / SponsorPhaseRating
Safinamide
Zambon SpA
Phase 4A
Cvt-301
Acorda Therapeutics
Phase 3A
Istradefylline
Georgetown University
Phase 4BBB
Pardoprunox
Abbott Products
Phase 3BBB
Tvp-1012
Guangzhou Henovcom Bioscience Co. Ltd.
Phase 4BBB

View all 50 →

Same molecule, other indications

Ropinirole is also rated in:

restless legs syndromeDormant
A
Indicative ·
81 / 100
View asset →
Parkinson diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
drug-induced dyskinesiaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →